Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 12/03/20011 min de lecture
Draft Guidance for Industry on Postmarketing Safety Reporting for Human Drug and Biological Products Including Vaccines; Availability
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Postmarketing Safety Reporting for Human Drug and Biological Products Including Vaccines." This draft guidance is intended to assist applicants and other responsible parties in fulfilling FDA's postmarketing safety reporting requirements for marketed human drugs and biological products.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →